cbdMD (YCBD) to Release Quarterly Earnings on Wednesday

cbdMD (NYSEAMERICAN:YCBD) is expected to be releasing its Q2 2026 results after the market closes on Wednesday, May 20th. Analysts expect cbdMD to post earnings of ($0.05) per share and revenue of $5.2920 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, May 14, 2026 at 4:20 PM ET.

cbdMD Trading Down 3.0%

YCBD stock opened at $0.78 on Wednesday. cbdMD has a 52-week low of $0.47 and a 52-week high of $2.56. The business has a 50-day simple moving average of $0.78 and a two-hundred day simple moving average of $0.88.

Hedge Funds Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC bought a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned approximately 0.49% of cbdMD as of its most recent SEC filing. 7.18% of the stock is owned by institutional investors.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.